Body mass index, waist circumference, and the risk of type 2 diabetes mellitus: implications for routine clinical practice.

BACKGROUND Current guidelines for assessing the risk of developing type 2 diabetes mellitus (DM) recommend using the patient's body-mass index (BMI) as a primary measure. Waist circumference measurement is recommended for overweight or obese patients only (BMI > or = 25). METHODS We studied the interaction between BMI and waist circumference with respect to the risk of developing type 2 DM in a cohort of 9753 men and 15491 women, aged 35 to 65, who participated in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam. The statistical analysis was performed with multivariable-adjusted Cox proportional hazard regression. RESULTS During a mean follow-up interval of 8 years, type 2 DM was newly diagnosed in 583 men and 425 women. A statistically significant interaction was found between BMI and waist circumference with respect to the risk of type 2 DM (p<0.0001). The positive association between waist circumference and diabetes risk was stronger in persons with lower BMI. The relative risk (RR) of developing type 2 DM among persons of low or normal weight (BMI < 25) who had a large waist circumference was at least as high as that among overweight persons (BMI 25-29.9) with a small waist circumference: for the first case, the RR was 3.62 [1.67-7.83] in men and 2.74 [1.52-4.94] in women; for the second case, the RR was 2.26 [1.51-3.37] in men and 1.40 [0.61-3.19] in women (The figures in square brackets are 95% confidence intervals). These relative risks were calculated in comparison to the risk among persons of low or normal weight (BMI < 25) with a small waist circumference. CONCLUSION These findings imply that the waist circumference is an important additional piece of information for assessing the risk of type 2 DM, particularly among persons of low or normal weight.

[1]  Yuji Yamamoto,et al.  Beneficial effects of subcutaneous fat transplantation on metabolism. , 2008, Cell metabolism.

[2]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[3]  B. Bengtsson,et al.  Growth hormone and the metabolic syndrome. , 1999, Journal of endocrinological investigation.

[4]  Henry Völzke,et al.  The predictive value of different measures of obesity for incident cardiovascular events and mortality. , 2010, The Journal of clinical endocrinology and metabolism.

[5]  E L Korn,et al.  Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. , 1997, American journal of epidemiology.

[6]  H. Boeing,et al.  Recruitment Procedures of EPIC-Germany , 1999, Annals of Nutrition and Metabolism.

[7]  H. Pijl,et al.  Adipose tissue as an endocrine organ: impact on insulin resistance. , 2003, The Netherlands journal of medicine.

[8]  J. Benichou,et al.  Choice of time‐scale in Cox's model analysis of epidemiologic cohort data: a simulation study , 2004, Statistics in medicine.

[9]  U. Nöthlings,et al.  Obesity and cancer , 2008, Proceedings of the Nutrition Society.

[10]  A. Kissebah,et al.  Regional adiposity and morbidity. , 1994, Physiological reviews.

[11]  J. Shaw,et al.  Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[12]  J Michael Gaziano,et al.  Measures of obesity and cardiovascular risk among men and women. , 2008, Journal of the American College of Cardiology.

[13]  J F Sallis,et al.  Compendium of physical activities: classification of energy costs of human physical activities. , 1993, Medicine and science in sports and exercise.

[14]  P. B. Eveleth,et al.  Physical Status: The Use and Interpretation of Anthropometry. Report of a WHO Expert Committee , 1996 .

[15]  M. Schulze,et al.  General and abdominal adiposity and risk of death in Europe. , 2008, The New England journal of medicine.

[16]  J. Pankow,et al.  Sensitivity and specificity of anthropometrics for the prediction of diabetes in a biracial cohort. , 2001, Obesity research.

[17]  P. Björntorp,et al.  Fat cell metabolism in different regions in women. Effect of menstrual cycle, pregnancy, and lactation. , 1985, The Journal of clinical investigation.

[18]  A Tremblay,et al.  Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. , 1990, Arteriosclerosis.

[19]  Judith Wylie-Rosett,et al.  Nutrition Recommendations and Interventions for Diabetes , 2008, Diabetes Care.

[20]  David W. Hosmer,et al.  Applied Survival Analysis: Regression Modeling of Time-to-Event Data , 2008 .

[21]  Paul Zimmet,et al.  The metabolic syndrome—a new worldwide definition , 2005, The Lancet.

[22]  J. Prins,et al.  The link between abdominal obesity and the metabolic syndrome , 2008, Current hypertension reports.

[23]  S. O’Rahilly,et al.  The perils of portliness: causes and consequences of visceral adiposity. , 2000, Diabetes.

[24]  P. Björntorp.  Metabolic Implications of Body Fat Distribution , 1991, Diabetes Care.

[25]  Barbara Thorand,et al.  Body fat distribution and risk of type 2 diabetes in the general population: are there differences between men and women? The MONICA/KORA Augsburg cohort study. , 2006, The American journal of clinical nutrition.

[26]  C. Bouchard,et al.  Visceral fat in relation to health: is it a major culprit or simply an innocent bystander? , 1997, International Journal of Obesity.

[27]  J. Flier,et al.  Obesity and insulin resistance. , 2000, The Journal of clinical investigation.

[28]  Heiner Boeing,et al.  Comparison of Anthropometric Characteristics in Predicting the Incidence of Type 2 Diabetes in the EPIC-Potsdam Study A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances. , 2006, Diabetes Care.

[29]  H. Yki-Järvinen,et al.  Effects of Body Composition on Insulin Sensitivity , 1983, Diabetes.

[30]  Walter C Willett,et al.  Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. , 2005, The American journal of clinical nutrition.

[31]  S. Heymsfield,et al.  Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds. , 2002, The American journal of clinical nutrition.

[32]  Philipp E. Scherer,et al.  Visceral Fat Adipokine Secretion Is Associated With Systemic Inflammation in Obese Humans , 2007, Diabetes.

[33]  H Boeing,et al.  Interviewer variability in anthropometric measurements and estimates of body composition. , 1997, International journal of epidemiology.